Test of a learning tool during leukemia maintenance
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study checks whether a tablet-based tool (called PeNAT) can be used by children during the usual maintenance treatment phase for ALL (a type of leukemia). It may help families and clinicians better support care at home or during follow-up by testing how well the tool works in real patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 4 years or older.
- Your ALL is newly diagnosed and you are in maintenance treatment, or it has come back (recurrent) but you are not relapsed in this study’s maintenance phase.
- You and your main caregiver can speak English, French, or Spanish (and PeNAT is available in those languages).
- You can physically and mentally use the PeNAT tool (no issues that would prevent using it).
- You are planned to take 6-mercaptopurine by mouth during the study.
- During the 7-day study period, you will not receive chemotherapy by IV/shot into muscle/under the skin/in the spinal fluid, and you will not take corticosteroids by mouth or through an IV.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a mobile health program to help teens and young adults with leukemia sit less during their maintenance therapy. The program uses a fitness tracker and group support to encourage more movement, which may improve health and well-being.
This trial tests whether using a mobile app to track daily medication and weekly blood tests can help children with acute lymphoblastic leukemia (ALL) continue maintenance therapy safely at home, without needing to stay in the hospital.
This trial tests a mobile (phone) health program to help adolescents and young adults with leukemia take their oral chemotherapy medicine consistently. It may help if staying on daily pills is hard during the maintenance phase of treatment.
This study tests a support program that helps parents give their child's daily leukemia medicine (6-MP) on schedule and overcome any barriers. It aims to make it easier for families to stick with treatment.
This trial tests a bilingual, online program to help children and teens who have ALL (a type of leukemia) stay at a healthy weight during the maintenance phase of treatment. It may help lower the chance of gaining too much weight while on chemotherapy.
This study tests if a computer-based training program focusing on thinking skills and mindfulness can help children and teens who have had leukemia treatment. It may help improve memory, attention, and emotional well-being.
Hear when a new Acute Lymphoblastic Leukemia (ALL) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.